OR WAIT null SECS
August 02, 2020
EU regulators are requesting more effective action be taken to tackle serious impurities in APIs and finished products.
COVID-19’s impact on the global economy is dealing a blow to merger and acquisition activity in the biopharma industry.
July 30, 2020
Vico Therapeutics has raised $31 million (€27 million) in a Series A financing round, which the company will use to further advance its Antisense OligoNucleotides lead platform.
PCI Pharma has announced the creation of a new clinical center of excellence in Western Europe at its site in Berlin, Germany.
EMA has started a review of dexamethasone as a treatment for adults with COVID-19 who require respiratory support and have been admitted to hospital.
EMA's CHMP has adopted a positive opinion for Dapivirine Vaginal Ring for women in non-EU countries where HIV disease burden is high.
Pharmapack Europe 2021 has been rescheduled after a careful review by the event organizers with key stakeholders.
Avacta Group has expanded its partnership with Daewoong Pharmaceutical to include Affimer molecules that target viruses, such as coronavirus.
July 29, 2020
Celltrion Healthcare has announced that the EC has granted marketing authorization for its subcutaneous formulation of Remsima (infliximab, CT-P13).
Sterling Pharma Solutions has signed a deal with Moleculin Biotech to support the development of WP1122, a potential COVID-19 treatment.